Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
The Falls Efficacy Scale International: A Cross-Sectional Validation in People with Multiple Sclerosis.
Late-onset Multiple Sclerosis in Isfahan, Iran.
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
Neuromyelitis optica mimicking intramedullary tumor.
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.
Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
Purines in neurodegeneration and neuroregeneration.
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
Role of socio-economic and reproductive factors in the risk of multiple sclerosis.
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
The MiRNA Journey from Theory to Practice as a CNS Biomarker.
Nicotine might have a protective effect in the etiology of multiple sclerosis.
Pelvic floor disorders and multiple sclerosis: are patients satisfied with their care?
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice.
Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
452
453
454
455
456
457
458
459
460
…
next ›
last »